BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs3825942
,
PTEN
,
T cell differentiation
,
HIV infection
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
VLDL, triglyceride
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Affects of fenofibrate, PFBS, PFOS and PFHxS on liver expression in APOE*3-Leiden.CETP mice
Skeletal myotubes treated with oleic acid, SBI-477 or DGAT inhibitor A922501
Liver tissue of MAT1A knockout mice treated with S-adenosylmethionine (SAMe)
Explore Curated Studies Results
Literature
Most Relevant Literature
Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein li…
Comprehensive in-silico analysis of deleterious SNPs in APOC2 and APOA5 and their differential expre…
Apolipoprotein C-II: the re-emergence of a forgotten factor.
Genetic Variants Associated with Severe Hypertriglyceridemia: LPL, APOC2, APOA5, GPIHBP1, LMF1, and …
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the la…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride …
Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD
Very Low Density Lipoprotein (VLDL) Triglyceride Metabolism in Exercise
Body Composition and Very-Low-Density-Lipoprotein-Triglycerides (VLDL-TG) Kinetics
Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ